Loading patent…
AssigneesRiken, Animal Allergy Clinical Laboratories Inc.
InventorsKenichi MASUDA, Takashi SAITO, Yasuyuki ISHII, Ayato TAKADA, Manabu IGARASHI, Junki MARUYAMA, Yusuke SAITO, Takuya NARA
Estimating the term…
This application relates to an useful drug for prevention or treatment of avian influenza virus infection, and specifically provides a multiple antigen peptide comprising a dendritic core and 4-8 antigen peptides, wherein each of the antigen peptides is bound to a terminus of the dendritic core directly or through a spacer, and is a peptide consisting of 7-12 consecutive amino acids in the amino acid sequence of SEQ ID NO: 4, the multiple antigen peptide inducing the production of IgG antibodies in mammalian animals or birds, and further provides an immunity inducer comprising the multiple antigen peptide.
A multiple antigen peptide comprising a dendritic core and 4-8 antigen peptides, wherein each of the antigen peptides is bound to a terminus of the dendritic core directly or through a spacer, and is a peptide consisting of 7-12 consecutive amino acids in the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.